Production & Manufacturing
Drug Research
WHO & Republic of Korea Tie-Up For Biomanufacturing Training
The World Health Organisation as well as the Republic of South Korea have gone ahead and inked a MoU so as to establish a worldwide...
BioPharma
Cell and Gene Therapy CDMO Targets North American Growth...
uBriGene, a cell & gene therapy contract development and manufacturing organization (CDMO), is expanding into the US market with the acquisition of a state-of-the-art GMP...
News
UNDBIO to Build $100M Insulin Manufacturing Facility in West...
UNDBIO, a South Korean pharmaceutical company focused on diabetic care, will spend $100 million to build an insulin manufacturing facility in West Virginia.
The project is expected...
Press Releases
Lonza’s API Mid-Scale Manufacturing Facility Expansion in Nansha Enters...
Lonza announces the start of new mid-scale manufacturing assets at its API manufacturing center in Nansha, China. Commercial mid-scale operations are now underway at the...
News
How ‘First-Time Right’ Formulations Can Help Address the Challenge...
For years, global healthcare systems have been facing the triple threat of rising incidences of long-term conditions (LTC), aging populations and dwindling resources. At the...
News
By 2030, OSD Contract Manufacturing Will Be $54.7 Billion
The global oral solid dosage (OSD) contract manufacturing market is anticipated to reach $54.7 billion in value by 2030, exhibiting a compound annual growth rate...
News
By 2026, Pharma Contract Manufacturing To Be Worth $130bn
The global pharmaceutical contract manufacturing market is anticipated to reach $130.2 billion by 2026 as a result of increasing demand for pharmaceuticals, particularly in developing...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.